Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 19;108(16):6615-20.
doi: 10.1073/pnas.1016217108. Epub 2011 Apr 5.

Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism

Affiliations

Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism

Azam Hassaninasab et al. Proc Natl Acad Sci U S A. .

Abstract

Polyphenol curcumin, a yellow pigment, derived from the rhizomes of a plant (Curcuma longa Linn) is a natural antioxidant exhibiting a variety of pharmacological activities and therapeutic properties. It has long been used as a traditional medicine and as a preservative and coloring agent in foods. Here, curcumin-converting microorganisms were isolated from human feces, the one exhibiting the highest activity being identified as Escherichia coli. We are thus unique in discovering that E. coli was able to act on curcumin. The curcumin-converting enzyme was purified from E. coli and characterized. The native enzyme had a molecular mass of about 82 kDa and consisted of two identical subunits. The enzyme has a narrow substrate spectrum, preferentially acting on curcumin. The microbial metabolism of curcumin by the purified enzyme was found to comprise a two-step reduction, curcumin being converted NADPH-dependently into an intermediate product, dihydrocurcumin, and then the end product, tetrahydrocurcumin. We named this enzyme "NADPH-dependent curcumin/dihydrocurcumin reductase" (CurA). The gene (curA) encoding this enzyme was also identified. A homology search with the BLAST program revealed that a unique enzyme involved in curcumin metabolism belongs to the medium-chain dehydrogenase/reductase superfamily.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
SDS/PAGE of the purified curcumin-converting enzyme. Protein bands were detected by staining with Coomassie brilliant blue. Lane M, marker proteins; lane 1, the purified enzyme (1 μg).
Fig. 2.
Fig. 2.
The reaction products, dihydrocurcumin (DHC), and tetrahydrocurcumin (THC). (A) LC-ESI-MS spectrum of THC in the positive ion mode. (B) UV-vis spectrum of THC. (C) LC-ESI-MS spectrum of DHC in the positive ion mode. (D) UV-vis spectrum of DHC.
Fig. 3.
Fig. 3.
Time course of curcumin conversion and generation of products. Curcumin (▲), DHC (●), and THC (■).
Fig. 4.
Fig. 4.
Curcumin metabolic pathway.
Fig. 5.
Fig. 5.
CD spectra of the curcumin-converting enzyme and the ellipticity in different pH values. The CD spectra of CurA treated in 10-mM Britton-Robinson buffer pH 6.0 (A) and pH 2.1 (B); 0.1 mg/mL of the purified enzyme was treated at different pH values in 10-mM Britton-Robinson buffer and CD spectra were measured. The mollar ellipticity (θ) was then calculated for the different pHs. θ222 was denoted by dotted line. (C) θ222 at different pH values. The CD spectra of CurA after the pH was shifted from 6.0 to 6.0 (D) and from 2.1 to 6.0 (E); 0.1 mg/mL of the purified enzyme was treated at different pH values in 10-mM Britton-Robinson buffer and then shifted to the usual pH 6.0 using 40-mM Britton-Robinson buffer (pH 6.0), and then the CD spectrum was measured and θ222 was denoted by a dotted line. (F), θ222 after the pH had been shifted from various values to 6.0.

References

    1. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The Indian solid gold. Adv Exp Med Biol. 2007;595:1–75. - PubMed
    1. Sharma RA, Gescher AJ, Steward WP. Curcumin: The story so far. Eur J Cancer. 2005;41:1955–1968. - PubMed
    1. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65:1631–1652. - PMC - PubMed
    1. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem. 2007;102:1095–1104. - PubMed
    1. Nandakumar DN, Nagaraj VA, Vathsala PG, Rangarajan P, Padmanaban G. Curcumin-artemisinin combination therapy for malaria. Antimicrob Agents Chemother. 2006;50:1859–1860. - PMC - PubMed

Associated data